Future therapies of Tourette syndrome

Neurologic Clinics

Volumn 15, Issue 2, 1997, Pages 429-450

  Chappell, P B ^a   Scahill, L D ^a   Leckman, J F ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CLOMIPRAMINE; CLONIDINE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE MALEATE; GUANFACINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PIMOZIDE; PREDNISONE; QUETIAPINE; RISPERIDONE; SELEGILINE; SERTINDOLE; SERTRALINE; SULPIRIDE; TALIPEXOLE; TETRABENAZINE; TIAPRIDE; ZIPRASIDONE;

AKATHISIA; BEHAVIOR THERAPY; CLINICAL RESEARCH; DEPRESSION; DROWSINESS; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GILLES DE LA TOURETTE SYNDROME; HORMONAL THERAPY; HUMAN; IMMUNOMODULATION; LEUKOPENIA; NEUROSURGERY; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; TARDIVE DYSKINESIA; TREATMENT PLANNING; VERTIGO;

EID: 0030999627     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70324-8     Document Type: Article

References (102)

1. C.H. Adler R.S. Zimmerman M.K. Lyons Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease Movement Disorders 11 1996 79 81
2. A.J. Allen H.L. Leonard S.E. Swedo Case study: A new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome J Am Acad Child Adolesc Psy chiatry 34 1995 307 311
3. G.M. Anderson E.S. Pollak D. Chatterjee Postmortem analysis of subcortical mono amines and amino acids in Tourette syndrome T.N. Chase A.J. Friedhoff D.J. Cohen Tourette Syndrome: Genetics, Neurobiology, and Treatment, Advances in Neurology Vol 58 1992 Raven Press New York 123 134
4. A.F.T. Arnsten J.C. Steere R.D. Hunt The contribution of alpha-2 adrenergic mechanisms to prefrontal cortical cognitive function: Potential significance to attention deficit disorder Arch Gen Psychiatry 53 1996 448 455
5. A.F.T. Arnsten T.A. Contant Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task Psychopharmacology 108 1992 159 169
6. J. Arnt C. Sanchez Differential effects of antipsychotic drugs on amphetamine-induced hypermotility, stereotype, and discriminative stimulus effects in rats abstract Soc Neurosci Abstr 19 1993 383
7. N.H. Azrin R.G. Nunn Habit-reversal: A method of eliminating nervous habits and tics Behav Res Therapy 11 1973 619 628
8. J. Balldin U. Berggren E. Eriksson Guanfacine as an alpha2-agonist inducer of growth hormone secretion—a comparison with clonidine Psychoneuroendocrinology 18 1993 45 55
9. C.M. Beasley G. Tollefson P. Tran Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial Neuropsy chopharmacology 14 1996 111 123
10. R.D. Bruun Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder Am J Psychiatry 145 1988 621 624
11. R.D. Bruun C.L. Budman Risperidone as a treatment for Tourette's syndrome J Clin Psychiatry 57 1996 29 31
12. E.D. Caine R.J. Polinsky M.H. Ebert Trial of chlorimipramine and desipramine for Gilles de la Tourette syndrome Ann Neurol 5 1979 305 306
13. E.D. Caine R.J. Polinsky R. Kartzinel The trial use of clozapine for abnormal in voluntary movement disorders Am J Psychiatry 136 1979 317 320
14. A. Carlson Searching for the ideal antipsychotic agent. Part 1 abstract Neuropsycho pharmacology 10 3Suppl May 1994 243S
15. P.B. Chappell M. Riddle G. Anderson Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture Biol Psychiatry 36 1994 35 43
16. P.B. Chappell J.F. Leckman M.A. Riddle The pharmacologic treatment of tic disorders Child Adolesc Psychiatr Clin North Am 4 1995 197 216
17. P.B. Chappell M.A. Riddle L. Scahill Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience J Am Child Adolesc Psychiatry 34 1995 1140 1146
18. Chappell PB, Leckman JF, Goodman WK, et al: Elevated levels of CSF corticotropin-releasing factor in Tourette's patients: Comparison to obsessive-compulsive disorder and normal controls. Biol Psychiatry 39:776–783
19. G. Chouinard B. Jones G. Remington A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients J Clin Psychopharmacol 13 1993 25 40
20. A.Y. Deutch Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: Implications for schizophrenia and Parkinson's disease J Neural Transmis 91 1993 197 221
21. S.M. Dursun J.G. Burke M.A. Reveley Buspirone treatment of Tourette's syndrome Lancet 345 1995 1366 1367
22. C.H. Eggers A. Rothenberger U. Berghaus Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride Europ Arch Psychiatry Neurol Sci 237 1976 223 229
23. G. Erenberg R.P. Cruse A.D. Rothner The natural history of Tourette syndrome: A follow-up study Ann Neurol 22 1987 383 385
24. G. Erenberg Treatment of Tourette syndrome with neuroleptic drugs T.N. Chase A.J. Friedhoff D.J. Cohen Advances in Neurology vol 58 1992 Raven Press New York 241 243
25. A.E. Farmer A. Blewett Drug treatment of resistant schizophrenia: Limitations and recommendations Drugs 45 1993 374 383
26. A. Feigin A. Kurlan M.P. McDermott A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder Neurology, 46 1996 965 968
27. I. Fras Guanfacine for Tourette's disorder letter J Am Acad Child Adolesc Psychiatry 35 1996 34
28. 2 receptors Life Sci 88 1983 11 26
29. J. Gerlach New antipsychotics: Classification, efficacy, and adverse effects Schizophren Bull 17 1991 289 309
30. J. Gerlach L. Peacock New antipsychotics: The present status Int Clin Psychopharmacol 10 Suppl 3 1995 39 48
31. J.N. Giedd J.L. Rapoport M.J.P. Kruesi Sydenham's chorea: Magnetic resonance imaging of the basal ganglia neurology 45 1995 2199 2202
32. W.J. Giakas Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder Am J Psychiatry 152 1995 1097 1098
33. C.G. Goetz Clonidine R. Kurlan Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders 1993 Marcel Dekker New York 377 388
34. C.G. Goetz G.T. Stebbins J.A. Thelen Talipexole and adult Gilles de la Tourette's syndrome: Double-blind, placebo-controlled clinical trial Movement Disorders 9 1994 315 317
35. J.M. Goldstein The profile of Seroquel in preclinical tests for antipsychotic atypicality Part 2 Neuropsychopharmalcology 10 3suppl May 1994 121
36. T.G. Heffner Comparative activity profiles of dopamine autoreceptor agonists in preclinical tests. Part 1 abstract Neuropsychopharmacology 10 3suppl 1994 120
37. A. Hillert W. Maier H. Wetzel Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome—A functional approach Pharmacopsychiatry 25 1992 213 217
38. J.C. Holzer W.K. Goodman C.J. McDougle Obsessive-compulsive disorder with and without a chronic tic disorder: A comparison of symptoms in 70 patients Br J Psychiatry 164 1994 469 473
39. J.P. Horrigan L.J. Barnhill Guanfacine for treatment of attention-deficit hyperactivity disorder in boys J Child Adolesc Psychopharmacol 5 1995 215 223
40. R.D. Hunt A.F.T. Arnsten M. Asbell An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder J Am Acad Child Adoles Psychiatry 34 1995 50 54
41. Jacobsen FM: Risperidone in the treatment of severe affective illness and refractory OCD Abstract NR275:129 In New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association, May 23, 1995, Miami, Fla.
42. E. Jaffe F. Tremeau Z. Sharif Clozapine in tardive Tourette syndrome Biol Psychiatry 38 1995 196 197
43. J. Jankovic Deprenyl in attention deficit associated with Tourette's disorder Arch Neurol 50 1993 286 288
44. J. Jankovic Botulinum toxin in the treatment of dystonic tics Movement Disorders 9 1994 347 349
45. J. Jankovic J. Orman Tetrabenazine therapy of dystonia, chorea, tics, and other hyperkinesias Neurology 38 1988 391 394
46. M. Kalian V. Lerner M. Goldman Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine J Nerv Ment Dis 181 1993 649 651
47. J.M. Kane Understanding and treating psychoses: Advances in research and therapy J Clin Psychiatry 54 1993 445 452
48. L.S. Kiessling A.C. Marcotte L. Culpepper Antineuronal antibodies in movement disorders Pediatrics 92 1993 39 43
49. L.S. Kiessling A.C. Marcotte M. Benson Relationship between GABHS and childhood movement disorders Pediatr Res 33 1993 12A
50. R. Kurlan The pathogenesis of Tourette's syndrome Arch Neurol 49 1992 874 876
51. R. Kurlan P.G. Como C. Deeley A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome Clin Neuropharmacol 16 1993 167 172
52. J.F. Leckman J. Detlor D.F. Harcherik Short- and long-term treatment of Tourette's syndrome with clonidine: A clinical perspective Neurology 35 1985 343 351
53. J.F. Leckman S. Ort K.A. Caruso Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine Arch Gen Psychiatry 43 1986 1168 1176
54. J.F. Leckman M.T. Hardin M.A. Riddle Clonidine treatment of Gilles de la Tourette's syndrome Arch Gen Psychiatry 48 1991 324 328
55. J.F. Leckman D.L. Pauls D.J. Cohen Tic Disorders F.E. Bloom D. Kupfer Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press New York 1665 1674
56. J.F. Leckman W.K. Goodman G.M. Anderson CSF biogenic amines in obsessive compulsive disorder, Tourette's syndrome and healthy controls Neuropsychopharmacology 12 1995 73 86
57. J.A. Lieberman Understanding the mechanisms of action of atypical antipsychotic drugs: A review of compounds in use and development Br J Psychiatry 163 Suppl 22 1993 7 18
58. Lipinski JF, Salle FR, Jackson C, et al: Dopamine agonist treatment of Tourette disorder in children: Results of an open-label trial of pergolide. Movement Disorders, in press
59. P.J. Lombroso L. Scahill R.A. King Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report J Am Acad Child Adolesc Psychiatry 34 1995 1147 1152
60. P.J. Lombroso G. Mack L. Scahill Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: A family study Neurology 41 1991 1984 1987
61. C.J. McDougle W.K. Goodman L.H. Price Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder Am J Psychiatry 147 1990 652 654
62. C.J. McDougle W.K. Goodman J.F. Leckman Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder Arch Gen Psychiatry 51 1994 302 308
63. C.J. McDougle W.K. Goodman L.H. Price Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder J Clin Psychiatry 55 Suppl 1994 24 31
64. C.J. McDougle L.C. Barr W.K. Goodman Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder Am J Psychiatry 152 1995 1812 1814
65. J.S. March Cognitive-behavioral psychotherapy for children and adolescents with OCD: A review and recommendations for treatment J Am Acad Child Adolesc Psychiatry 34 1995 7 18
66. S.R. Marder R.C. Meibach Risperidone in the treatment of schizophrenia Am J Psychiatry 151 1994 825 835
67. H.Y. Meltzer Atypical antipsychotic drugs F.E. Bloom D.J. Kupfer Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press New York 1277 1286
68. M.W. Mandoki Risperidone treatment of children and adolescents: Increased risk of extrapyramidal side effects? J Child Adolesc Psychopharmacol 5 1995 49 67
69. H. Pakkenberg The effect of tetrabenazine in some hyperkinetic syndromes Acta Neurol Scand 44 1968 391 393
70. D.L. Pauls K.E. Towbin J.F. Leckman Gilles de la Tourette's syndrome and obsessive compulsive disorder: Evidence supporting a genetic relationship Arch Gen Psychiatry 43 1986 1180 1182
71. D.L. Pauls C.L. Raymond J. Stevenson A family study of Gilles de la Tourette syndrome Am J Hum Genet 48 1991 154 163
72. A.I. Peterson N.H. Azrin An evaluation of behavioral treatments for Tourette syndrome Behav Res Therapy 30 1992 167 174
73. A.L. Peterson N.H. Azrin Behavioral and pharmacological treatments for Tourette syndrome: A review Applied Preventive Psychology 2 1993 231 242
74. B.S. Peterson J.F. Leckman L. Scahill Steroid hormones and Tourette's syndrome: Early experience with antiandrogen therapy J Clin Psychopharmacol 14 1994 131 135
75. B.S. Peterson Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome J Clin Psychiatry 57 Suppl 9 1996 24 34
76. Physician's Desk Reference ed 48 1994 Medical Economics Oradell, NJ 977 979
77. R.A. Price J.F. Leckman D.L. Pauls Gilles de la Tourette syndrome Neurology 36 1986 232 237
78. N. Poungvarin V. Devahastin A. Viriyavejakul Treatment experience of various movement disorders with botulinum A toxin injection: An experience of 900 patients J Med Assoc Thailand 78 1995 281 288
79. G. Ratzoni H. Hermesh N. Brandt Clomipramine efficacy for tics, obsessions and compulsions in Tourette's syndrome and obsessive-compulsive disorder: A case study Biol Psychiatry 27 1990 95 98
80. S.L. Rauch L. Baer G.R. Cosgrove Neurosurgical treatment of Tourette's syndrome: A critical review Comprehen Psychiatry 36 1995 141 156
81. L. Reguer B. Pakkenberg R. Fog Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome J Neurol Neurosurg Psychiatry 49 1986 791 795
82. Reeves KR, Harrigan EP: The efficacy and safety of two fixed doses of ziprasidone in schizophrenia and schizoaffective disorder. Presented at the XXth Collegium Internationale Neuropsychopharmacologicum, Melbourne, Australia, June 1996
83. M.A. Riddle M.T. Hardin K.E. Towbin Tardive dyskinesia following haloperidol treatment for Tourette's syndrome letter Arch Gen Psychiatry 44 1987 98 99
84. M.A. Riddle L.S. Scahill R.A. King Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder J Am Acad Child Adolesc Psychiatry 32 1992 1062 1069
85. M.A. Riddle J.C. Nelson C.S. Kleinman Sudden death in children receiving Norpramin: A review of three cases and commentary J Am Acad Child Adolesc Psychiatry 32 1993 792 797
86. M.M. Robertson V. Schneiden A.J. Lees Management of Gilles de la Tourette syndrome using sulpiride Clin Neuropharmacol 3 1990 229 235
87. M.S. Ross H. Moldofsky A comparison of pimozide and haloperidol in the treatment of Gilles de Tourette syndrome Am J Psychiatry 135 1978 585 587
88. F.R. Sallee C.M. Rock Effects of pimozide on cognition in children with Tourette syndrome: Interaction with comorbid attention-deficit hyperactivity disorder Acta Psychiatr Scand 90 1994 4 9
89. Scahill L, Vitulano LA, Brenner EM, et al: Behavioral therapy in children and adolescents with obsessive-compulsive disorder: A pilot study. J Child Adolesc Psychopharmacol, in press
90. T.F. Seeger P.A. Seymour A.W. Schmidt Ziprasidone (CP–88,059): A new antipsychotic with combined dopamine and serotonin antagonist activity J Pharmacol Exp Ther 275 1995 101 113
91. R.R. Silva D.M. Munoz J. Barickman Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder J Child Psychol Psychiatry 36 1995 305 312
92. R.R. Silva D.M. Munoz W. Daniel Causes of discontinuation in patients with Tourette's disorder: Management and alternatives J Clin Psychiatry 57 1996 129 135
93. T. Silverstone Clinically relevant differences between antipsychotic compounds Acta Psychiatr Scand 82 suppl 358 1990 88 91
94. P. Sokoloff B. Giros M.-P. Martres Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 347 1990 146 151
95. M. Stamenkovic H. Aschauer S. Kasper Risperidone for Tourette's syndrome Lancet 344 1994 1577 1578
96. S.E. Swedo L.S. Kiessling Speculations on antineuronal antibodymediated neuropsychiatric disorders of childhood Pediatrics 93 1994 323 326
97. S.E. Swedo Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders JAMA 272 1994 1788 1791
98. D.M. Tucker J.F. Leckman L. Scahill A putative post-streptococcal case of obsessive compulsive disorder with chronic tic disorder, not otherwise specified Am J Child Adolesc Psychiatry, 35 1996 1684 1691
99. C. Van der Linden R. Bruggeman T. Van Woerkom Serotonine-dopamine antagonist and Gilles de la Tourette's syndrome: An open pilot dose-titration study with risperidone Mov Disord 9 1994 687 688
100. D.P. Van Kammen J.P. McEvoy S.D. Targum A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia Psychopharmacology 124 1996 168 175
101. H. Wetzel G. Grunder A. Hillert Roxindole, an autoreceptor-selective dopamine agonist, in the treatment of positive and negative symptoms abstract Neuropsychopharmacology 10 3Suppl, part 1 May 1994 123S
102. S.S. Wolf D.W. Jones M.B. Knable Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding Science 273 1996 1225 1227